This case-control study investigated the relationship between combined estrogen and progestin hormone replacement therapy (HRT) and breast cancer risk in middle-aged women. The study found no significant increase in breast cancer risk for women using HRT, with a potential reduction in risk for long-term users. These findings suggest that combined
